2 active warrant series covering 3,250,000 shares (~8.2% potential dilution); nearest expiry 2026-11-07.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.11 | Nov 7, 2026 38d | 2.0M | ITM | 5.0% | C$220K | Auto |
| warrant | $0.17 | Apr 12, 2028 560d | 1.3M | OTM | 3.2% | C$213K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
7 option grants covering 2,600,000 shares (~6.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.50 | Jun 30, 2027 273d | 525K | OTM | 1.3% | C$263K | Auto |
| option | $0.15 | Feb 13, 2028 501d | 350K | ITM | 0.9% | C$54K | Auto |
| option | $0.15 | Oct 4, 2028 735d | 75K | ITM | 0.2% | C$11K | Auto |
| option | $0.08 | Jul 2, 2029 1006d | 500K | ITM | 1.3% | C$40K | Auto |
| option | $0.35 | Jan 6, 2031 1559d | 525K | OTM | 1.3% | C$186K | Auto |
| option | $0.11 | Jan 28, 2032 1946d | 325K | ITM | 0.8% | C$36K | Auto |
| option | $0.18 | Jan 3, 2036 3382d | 300K | OTM | 0.8% | C$54K | Auto |
39,655,164 shares outstanding, plus 3,250,000 from warrants and 2,600,000 from options — a fully diluted 45,505,164 shares, or ~14.8% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
2 active warrant series covering 3,250,000 shares (~8.2% potential dilution); nearest expiry 2026-11-07.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.11 | Nov 7, 2026 38d | 2.0M | ITM | 5.0% | C$220K | Auto |
| warrant | $0.17 | Apr 12, 2028 560d | 1.3M | OTM | 3.2% | C$213K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
7 option grants covering 2,600,000 shares (~6.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.50 | Jun 30, 2027 273d | 525K | OTM | 1.3% | C$263K | Auto |
| option | $0.15 | Feb 13, 2028 501d | 350K | ITM | 0.9% | C$54K | Auto |
| option | $0.15 | Oct 4, 2028 735d | 75K | ITM | 0.2% | C$11K | Auto |
| option | $0.08 | Jul 2, 2029 1006d | 500K | ITM | 1.3% | C$40K | Auto |
| option | $0.35 | Jan 6, 2031 1559d | 525K | OTM | 1.3% | C$186K | Auto |
| option | $0.11 | Jan 28, 2032 1946d | 325K | ITM | 0.8% | C$36K | Auto |
| option | $0.18 | Jan 3, 2036 3382d | 300K | OTM | 0.8% | C$54K | Auto |
39,655,164 shares outstanding, plus 3,250,000 from warrants and 2,600,000 from options — a fully diluted 45,505,164 shares, or ~14.8% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
